NYSE:NVSTMedical Equipment
Should Envista’s Profit Turn, Product Launches and Buybacks Require Action From Envista Holdings (NVST) Investors?
Envista Holdings reported its fourth-quarter and full-year 2025 results in early February 2026, with quarterly sales of US$750.6 million and net income of US$32.9 million, and full-year sales of US$2.72 billion alongside a return to profitability with net income of US$47 million.
Alongside these results, Envista highlighted nearly US$100 million in revenue from new product launches, guided to 2%–4% core sales growth for 2026, and completed a buyback of 9.17 million shares, or 5.4% of its...